Abstract:p16 is a tumor suppressor gene frequently affected by hypermethylation of promoter CpG island in malignant disorders. Phenylhexyl isothiocyanate (PHI) has been shown to induce p16 hypomethylation in leukemia cells. However, the methylation status is usually studied qualitatively or semi-quantitatively at the best. In this study, we developed a novel method to quantify p16 methylation in clinical specimen from patients with hematological malignancies as well as in U266, a multiple myeloma cell line. To establish a standard curve of p16 promoter methylation, methylated and demethylated PCR products were subcloned into plasmids respectively. The clones were selected out as completely methylated and demethylated clones, respectively. The PCR products of the two clones were mixed at different ratios and analyzed on a mciroarray chip to produce a standard curve of methylation. p16 promoter methylation was determined in U266 cells. The baseline p16 methylation was 78.2% in U266 cells. The methylation was decreased to 61.7% and 54.8%, respectively in the presence of PHI of 5 and 10 uM, respectively. We further analyzed p16 methylation status in 7 patients' specimen, two from blood, 5 from bone marrow. Two patients had ALL, two had AML, one CLL, one MM, and one CMML. 3 patients have p16 gene hypermethylation at 17.7%, 47.5% and 84.3%, respectively. Hypomethylation occurred in two of the three patients' cells after PHI treatment in vitro (84.3% to 64.8%, and 47.5% to 25.4%). In conclusion, a quantitative microarray method was established for quantitation of p16 methylation status. This will be used for laboratory screening of hypomethylation drugs, such as PHI, and for clinical application to monitor therapeutic efficacy of hypomethylating drugs, such as azacitidine, and to prognostify patients based on p16 methylation level.

Microarray-based method for detecting methylation changes of p16Ink4a gene 5'-CpG islands in gastric carcinomas

Microarray-based Method for Detecting Methylation Changes of P16^ink4a Gene 5＇-Cpg Islands in Gastric Carcinomas

High-throughput Method for Detecting DNA Methylation

A Microarray to Analyze Methylation Patterns of P16ink4a Gene 5′-Cpg Islands

A methyl at ion-specific oligonucleotide microarray for quantitative analysis of p16 gene

Detection of p16 Hypermethylation in Gastric Carcinomas Using a Seminested Methylation-Specific PCR

Detection Of Methylation Of Human P16(Ink4a) Gene 5 '-Cpg Islands By Electrochemical Method Coupled With Linker-Pcr

A Novel Method of Microarray Quantitave Analysis of P16 CPG Island Methylation in Leukemia Cells from Patients with Hematological Malignancies.

Highly sensitive determination of the methylated p16 gene in cancer patients by microchip electrophoresis.

Methylation Pattern Analysis Using High‐throughput Microarray of Solid‐phase Hyperbranched Rolling Circle Amplification Products

Allele-specific Extension on Microarray for DNA Methylation Analysis.

Hypermethylated DNA as potential biomarkers for gastric cancer diagnosis.

Methylation of CpG Islands of P16 Associated with Progression of Primary Gastric Carcinomas

Analysis of DNA Methylation Patterns Associated with the Gastric Cancer Genome.

Colorimetric silver detection of methylation using DNA microarray coupled with linker-PCR.

Establishment of Microarray-Based Method for Quantificationally Detecting Methylation Changes of E-cadherin Gene Promoter

Methylation of P16 CpG Islands Correlated with Malignant Progression of Gastric Dysplasia in a Nested Case-Control Study

Detection of Multiple Gene Methylation and Expression in Gastric Carcinoma

Hypermethylation of CpG island at p16 gene promoter in gastric carcinomas

Methylation Of P16 Cpg Islands Associated With Malignant Transformation Of Gastric Dysplasia In A Population-Based Study

Study of P16 Tumor Suppressor Gene with Methylation-Specific PCR